| Organovo Holdings is a biotechnology company that focuses on building 3D tissues that recapitulate primary aspects of human disease. Co. uses these models to identify gene targets responsible for driving the disease and initiates drug discovery programs around these validated targets. Co.'s NovoGen Bioprinters® are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Co.'s NovoGen Bioprinters® can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Co.'s NovoGen Bioprinters® also serve as components of its tissue prototyping and manufacturing platform. We show 41 historical shares outstanding datapoints in our ONVO shares outstanding history coverage, used to compute ONVO market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ONVO market cap history over the course of time is important for investors
interested in comparing ONVO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ONVO versus a peer is one thing; comparing
ONVO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ONVO can fluctuate over the course of history.
With this page we aim to empower investors researching ONVO by allowing them to research the ONVO market cap history.